FDA Approves Device for Weight Loss
Scripps Clinic experts weighs in on clinical trial and patient success
On Jan. 15 the Food and Drug Administration approved a vagal nerve stimulator for the treatment of obesity. Ken Fujioka, MD, and Mark Takata, MD, both of the Scripps Clinic Center for Weight Management shared their expertise with the media.
Read the Everyday Health interview Weighing In on New Obesity Treatment
The Sci-Tech Today interview FDA Approves a Device for Weight Loss is no longer available.
Media Contact
- Kristin Reinhardt
- 619-686-3787
- reinhardt.kristin@scrippshealth.org
- Follow me: @KReinhardt_SD